Natural Alternatives Q4 net sales up 18% to $52.5M; guides FY2023 sales growth 10-15%

NATURAL ALTERNATIVES INTERNATIONAL INC

Q4 net sales $52.5M (+18.3% YoY); net income $3.1M ($0.52 diluted EPS) vs $3.0M ($0.47) in Q4 FY2021.
Full-year FY2022 net sales $171.0M (-4.2%); net income $10.7M ($1.74 diluted EPS) vs $10.8M ($1.69) in prior year.
Private-label contract manufacturing Q4 up 25.6% to $49.9M; new e-commerce customer drove increase.
CarnoSyn royalty/licensing/raw material sales Q4 down 43.6% to $2.6M due to market/seasonal factors.
Guidance: FY2023 net sales +10-15%, operating income 5-7% of sales; inflation headwinds noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.